In obese breast-cancer patients, in which adipokines such as leptin and resistin known to be related to obesity and that increase mammary tumor risk, an elevation of FABP4 correlated with tumor size and stage, and with lymph node invasion was found (Hancke et al. 2010). This evidence concerns the gene FABP4 and neoplasm.